News
2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback